IGF1R and Alzheimer disease: In Alzheimer’s disease research, Chen et al. were the first to reveal the role of SUMOylation in regulating neuroinflammation, particularly through SUMO modification of the insulin-like growth factor 1 receptor (IGF1R) in influencing neuroinflammation (Chen et al., 2024a).